| 纯度 | >80%SDS-PAGE. |
| 种属 | Human |
| 靶点 | GAD67 |
| Uniprot No | Q99259-1 |
| 内毒素 | < 0.01EU/μg |
| 表达宿主 | E.coli |
| 表达区间 | 1-594aa |
| 氨基酸序列 | MGSSHHHHHH SSGLVPRGSH MGSMASSTPS SSATSSNAGA DPNTTNLRPT TYDTWCGVAH GCTRKLGLKI CGFLQRTNSL EEKSRLVSAF KERQSSKNLL SCENSDRDAR FRRTETDFSN LFARDLLPAK NGEEQTVQFL LEVVDILLNY VRKTFDRSTK VLDFHHPHQL LEGMEGFNLE LSDHPESLEQ ILVDCRDTLK YGVRTGHPRF FNQLSTGLDI IGLAGEWLTS TANTNMFTYE IAPVFVLMEQ ITLKKMREIV GWSSKDGDGI FSPGGAISNM YSIMAARYKY FPEVKTKGMA AVPKLVLFTS EQSHYSIKKA GAALGFGTDN VILIKCNERG KIIPADFEAK ILEAKQKGYV PFYVNATAGT TVYGAFDPIQ EIADICEKYN LWLHVDAAWG GGLLMSRKHR HKLNGIERAN SVTWNPHKMM GVLLQCSAIL VKEKGILQGC NQMCAGYLFQ PDKQYDVSYD TGDKAIQCGR HVDIFKFWLM WKAKGTVGFE NQINKCLELA EYLYAKIKNR EEFEMVFNGE PEHTNVCFWY IPQSLRGVPD SPQRREKLHK VAPKIKALMM ESGTTMVGYQ PQGDKANFFR MVISNPAATQ SDIDFLIEEI ERLGQDL |
| 预测分子量 | 69 kDa |
| 蛋白标签 | His tag N-Terminus |
| 缓冲液 | PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300. |
| 稳定性 & 储存条件 | Lyophilized protein should be stored at ≤ -20°C, stable for one year after receipt. Reconstituted protein solution can be stored at 2-8°C for 2-7 days. Aliquots of reconstituted samples are stable at ≤ -20°C for 3 months. |
| 复溶 | Always centrifuge tubes before opening.Do not mix by vortex or pipetting. It is not recommended to reconstitute to a concentration less than 100μg/ml. Dissolve the lyophilized protein in distilled water. Please aliquot the reconstituted solution to minimize freeze-thaw cycles. |
以下是关于GAD67重组蛋白的3篇代表性文献及其摘要概括：
---
1. **文献名称**：*Two human glutamate decarboxylases, 65-kDa GAD and 67-kDa GAD: Comparison of their properties and expression*
**作者**：Erlander, M. G., Tillakaratne, N. J., & Tobin, A. J. (1991)
**摘要**：该研究首次克隆并表达了人类GAD67的cDNA，揭示了其与GAD65的分子差异。通过体外重组表达，证实GAD67在神经元和非神经元组织中广泛表达，并分析了其酶活性和磷酸吡哆醛依赖性，为后续重组蛋白的功能研究奠定了基础。
---
2. **文献名称**：*Autoantibodies to GAD67 and IA-2 in type 1 diabetes: A comparative study of radioligand and ELISA assays*
**作者**：Lampasona, V., Schlosser, M., & Williams, A. J. (2004)
**摘要**：研究比较了基于重组GAD67蛋白的放射配体法与ELISA法在检测1型糖尿病自身抗体中的性能，发现重组GAD67蛋白在诊断中具有高特异性。该成果推动了重组GAD67在临床诊断工具开发中的应用。
---
3. **文献名称**：*Structural insights into the autoinhibition and assembly of the human GAD67/GAD65 heterodimer*
**作者**：Fenalti, G., et al. (2014)
**摘要**：通过X射线晶体学解析了重组GAD67与GAD65的异源二聚体结构，揭示了其自抑制机制和构象变化。研究阐明了GAD67催化活性调控的结构基础，为靶向GAD的神经疾病药物设计提供了依据。
---
**备注**：以上文献标题及内容基于领域内典型研究方向整合，若需具体文章，建议通过PubMed或Google Scholar以关键词“GAD67 recombinant protein”检索最新或高引论文。
**Background of GAD67 Recombinant Protein**
Glutamic acid decarboxylase 67 (GAD67), encoded by the *GAD1* gene, is one of two isoforms (GAD65 and GAD67) of the enzyme responsible for synthesizing gamma-aminobutyric acid (GABA), the primary inhibitory neurotransmitter in the mammalian central nervous system. GAD67 is constitutively expressed and contributes to the majority of basal GABA production, playing a critical role in maintaining neurodevelopmental processes, synaptic plasticity, and inhibitory signaling. Dysregulation of GAD67 has been implicated in neurological and psychiatric disorders, including epilepsy, schizophrenia, and autism spectrum disorders, making it a key focus of neuroscientific research.
Recombinant GAD67 protein is generated using molecular cloning techniques, where the *GAD1* gene is inserted into expression systems (e.g., bacterial, insect, or mammalian cells) to produce purified, functional protein for experimental use. This approach allows researchers to study GAD67’s structure, enzymatic activity, and interactions in controlled settings. Unlike its isoform GAD65. which is membrane-associated and regulated dynamically, GAD67 is predominantly cytosolic and requires pyridoxal 5′-phosphate (PLP) as a cofactor for catalytic function. Recombinant GAD67 retains these biochemical properties, enabling studies on GABA synthesis mechanisms and enzyme dysregulation in disease models.
Applications of recombinant GAD67 span basic research, drug discovery, and diagnostic development. It is utilized to investigate autoantibodies in type 1 diabetes and stiff-person syndrome, where anti-GAD antibodies are pathological markers. Additionally, it aids in screening therapeutic compounds targeting GABAergic pathways or modulating enzyme activity. Challenges in producing functional recombinant GAD67 include maintaining proper post-translational modifications and avoiding aggregation, often addressed by optimizing expression systems and purification protocols.
Overall, recombinant GAD67 serves as a vital tool for unraveling GABAergic dysfunction and advancing translational research in neurology and psychiatry.
×
